Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
RAMPs (receptor activity modifying proteins) impart remarkable effects on G protein-coupled receptor (GPCR) signaling. First identified through an interaction with the calcitonin receptor-like receptor (CLR), these single transmembrane proteins are now known to modulate the in vitro ligand binding affinity, trafficking, and second messenger pathways of numerous GPCRs. Consequently, the receptor-RAMP interface represents an attractive pharmacological target for the treatment of disease. Although the three known mammalian RAMPs differ in their sequences and tissue expression, results from in vitro biochemical and pharmacological studies suggest that they have overlapping effects on the GPCRs with which they interact. Therefore, to determine whether RAMP2 and RAMP3 have distinct functions in vivo, we generated mice with targeted deletions of either the RAMP2 or RAMP3 gene. Strikingly, we found that, although RAMP2 is required for survival, mice that lack RAMP3 appear normal until old age, at which point they have decreased weight. In addition, mice with reduced expression of RAMP2 (but not RAMP3) display remarkable subfertility. Thus, each gene has functions in vivo that cannot be accomplished by the other. Because RAMP2, RAMP3, and CLR transduce the signaling of the two potent vasodilators adrenomedullin and calcitonin gene-related peptide, we tested the effects of our genetic modifications on blood pressure, and no effects were detected. Nevertheless, our studies reveal that RAMP2 and RAMP3 have distinct physiological functions throughout embryogenesis, adulthood, and old age, and the mice we have generated provide novel genetic tools to further explore the utility of the receptor-RAMP interface as a pharmacological target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic deficiency in either adrenomedullin, Calcrl, or Ramp2 (27,57,74) is embryonic lethal at midgestation because of cardiovascular defects and a hypoproliferative lymphatic vasculature, whereas Ramp1 KO and Ramp3 KO are viable (57,131,203).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Calcrl Calcitonin receptor-like receptor (CRLR) Embryonic lethal (57, 74)”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
Krege, J. H., Hodgin, J. B., Hagaman, J. R., & Smithies, O. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1111 · Cited by 587
Self-citationChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Doods, H., Hallermayer, G., Wu, D., Entzeroth, M., Rudolf, K., Engel, W., & Eberlein, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703110 · Cited by 466
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Hay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
Koller, B. H., Hagemann, L. J., Doetschman, T., Hagaman, J. R., Huang, S., Williams, P. J., First, N. L., Maeda, N., & Smithies, O. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8927 · Cited by 223
Self-citationPharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes
Hay, D. L., Christopoulos, G., Christopoulos, A., Poyner, D. R., & Sexton, P. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008615 · Cited by 210
Bouschet, T., Martin, S., & Henley, J. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02598 · Cited by 169
Research works printed but not linked: 2
- Doods, 2001, Curr. Opin. Investig. Drugs, 2, 1261
- Gibbons, 2006, Mol. Endocrinol.
Cited by
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“Food and water intake was apparently unaltered in these animals and the reason for the difference in body weight is not yet known (Dackor et al., 2007).”
BackgroundAdrenomedullin signaling is necessary for murine lymphatic vascular development
Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33302 · Cited by 261
“However, our previous observations that RAMP3-null mice survive to adulthood with few phenotypic defects (34) demonstrates that RAMP3 is unable to fully replenish RAMP2-mediated AM signaling in vivo.”
BackgroundSelf-citationThe GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity
Ichikawa-Shindo, Y., Sakurai, T., Kamiyoshi, A., Kawate, H., Iinuma, N., Yoshizawa, T., Koyama, T., Fukuchi, J., Iimuro, S., Moriyama, N., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33022 · Cited by 201
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182
“RAMP2−/− are not viable, whereas RAMP3−/− show no abnormalities until 6 months, when they begin to fail to gain weight [48].”
BackgroundThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“(119) Calcrl Calcitonin receptor–like receptor (CRLR) Embryonic lethal (57, 74) Ramp1 Receptor activity–modifying protein (RAMP)1 NA Ramp2 RAMP2 Embryonic lethal (74) Ramp2 / (hemizygous): delayed bone development, reduced mineral content, and mineral density.”
BackgroundInfluentialSalvatore, C., Moore, E. L., Calamari, A., Cook, J. J., Michener, M. S., O'Malley, S. S., Miller, P. J., Sur, C., Williams, D. L., Zeng, Z., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163816 · Cited by 91
“, 2008), whereas the absence of RAMP3 had little or no effect until old age (Dackor et al., 2007).”
BackgroundNeuropeptide signalling orchestrates T cell differentiation
Hou, Y., Sun, L.-Y., LaFleur, M. W., Huang, L., Lambden, C., Thakore, P. I., Geiger-Schuller, K., Kimura, K., Yan, L., Zang, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08049-w · Cited by 96
Adrenomedullin – new perspectives of a potent peptide hormone
Schönauer, R. A.-R., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2017) · Journal of Peptide Science · doi:10.1002/psc.2953 · Cited by 89
Wootten, D., Lindmark, H., Kadmiel, M., Willcockson, H., Caron, K., Barwell, J., Drmota, T., & Poyner, D. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02202.x · Cited by 83
“Ramp2+/– mice on an isogenic 129S6/SvEv genetic background have been previously described ((Dackor et al., 2007; Kadmiel et al., 2011).”
BackgroundSelf-citationAdrenomedullin and tumour microenvironment
Larráyoz, I. M., Martínez-Herrero, S., García-Sanmartín, J., Ochoa‐Callejero, L., & Martínez, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0339-2 · Cited by 86
“RAMP3-null mice appear normal until old age (9-10 months), at which point they have less weight than their wild-type littermates [47].”
BackgroundLenhart, P. M., Broselid, S., Barrick, C. J., Leeb-Lundberg, L. M. F., & Caron, K. M. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0021 · Cited by 76
“The primer/probe set for Ramp3 has been previously described (Dackor et al. 2007).”
InfluentialSelf-citationCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“However, other strains such as Ramp1 KO and Ramp3 KO exhibit excellent viability [199, 201, 202].”
BackgroundHay, D. L., Walker, C. S., & Poyner, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0244 · Cited by 80
Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.009 · Cited by 81
Shared and separate functions of the RAMP-based adrenomedullin receptors
Kuwasako, K., Kitamura, K., Nagata, S., Hikosaka, T., Takei, Y., & Kato, J. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.022 · Cited by 76
Bench-to-bedside pharmacology of adrenomedullin
Kato, J., & Kitamura, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.061 · Cited by 79
“Mice without the RAMP2 gene were found to be embryo-lethal, but those without RAMP3 were born normally and could grow to adulthood (Dackor et al., 2007; Kadmiel et al., 2012; Yamauchi et al., 2014).”
BackgroundFernández, A. P., Serrano, J., Tessarollo, L., Cuttitta, F., & Martínez, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803174105 · Cited by 69
The calcium‐sensing receptor and its interacting proteins
Huang, C., & Miller, R. T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00114.x · Cited by 68
“Adrenomedullin and the CGRP affect vascular tone and blood pressure [38, 39].”
BackgroundAmylin Selectively Signals Onto POMC Neurons in the Arcuate Nucleus of the Hypothalamus
Lutz, T. A., Coester, B., Whiting, L., Dunn-Meynell, A. A., Boyle, C. N., Bouret, S. G., Levin, B. E., & Le Foll, C. (2018) · Diabetes · doi:10.2337/db17-1347 · Cited by 68
“Male RAMP1/3 double knockout (KO) mice (background: 129S6/SvEv [kindly donated by Kathleen Caron, University of South Carolina]) (30) and amylin KO (background: C57BL/6) (12) were bred, and 6-week-old WT and KO littermates were injected at dark onset after a 6-h fast with either saline or amylin (50 mg/kg) (n = 8/grou…”
MethodInfluentialChou, A., Chen, C., Chen, S., Chen, W., Chen, Y.-L., Weng, Y.-S., & Wang, H. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.11.003 · Cited by 77
Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Karpinich, N. O., Hoopes, S. L., Kechele, D. O., Lenhart, P., & Caron, K. M. (2011) · Current Hypertension Reviews · doi:10.2174/157340211799304761 · Cited by 60
Self-citationRAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis
Mackie, D. I., Nielsen, N. R., Harris, M., Singh, S., Davis, R. B., Dy, D., Ladds, G., & Caron, K. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905561116 · Cited by 56
“Importantly, we observed the same attenuation of guided angiogenesis in Ramp3 animals (29) compared to”
Self-citationDeficiency of RAMP1 Attenuates Antigen-Induced Airway Hyperresponsiveness in Mice
Li, M., Wetzel-Strong, S. E., Hua, X., Tilley, S. L., Oswald, E., Krummel, M. F., & Caron, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102356 · Cited by 50
“the interaction between CLR and RAMP3 also produces an AM receptor [8], although this does not appear to be the major AM receptor since Ramp3 mice are viable [9], in contrast to the embryonic lethality exhibited by Calcrl [10], Ramp2 [11] and Adm [12] mice.”
BackgroundSelf-citationElucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Kotliar, I. B., Lorenzen, E., Schwenk, J. M., Hay, D. L., & Sakmar, T. P. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000180 · Cited by 56
“Other RAMP3 null mice studies have pointed to a role for RAMP3 in negatively regulating bone adaptation (Dackor et al., 2007).”
BackgroundAdrenomedullin: Continuing to explore cardioprotection
Tsuruda, T., Kato, J., Kuwasako, K., & Kitamura, K. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.012 · Cited by 49
“RAMP3 mice displayed little or no effect except for small body size compared with the wild-type mice until old age [89].”
BackgroundHoopes, S. L., Willcockson, H. H., & Caron, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045261 · Cited by 48
“The apparently biased effects of AM signaling on the embryonic development of lymphatic vessels, versus blood vessels, is likely attributable to the increased expression of Calcrl and Ramp2 in LECs, compared to blood endothelial cells [18–20].”
InfluentialSelf-citationCoester, B., Pence, S. W., Arrigoni, S., Boyle, C. N., Le Foll, C., & Lutz, T. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.11.036 · Cited by 46
Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice1
Li, M., Wu, Y., & Caron, K. M. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.069336 · Cited by 45
“In support of this hypothesis is our finding that Calcrl/ and Ramp2/ female mice exhibit reduced fertility similarly to Adm þ/ mice, but female mice that are homozygous null for Ramp3 appear to have normal litter sizes [41].”
ResultSelf-citationKadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0400 · Cited by 44
Self-citationh CALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia
Mackie, D. I., Mutairi, F. A., Davis, R. B., Kechele, D. O., Nielsen, N. R., Snyder, J. C., Caron, M. G., Kliman, H. J., Berg, J. S., Simms, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180528 · Cited by 43
“20180528 2347 effects in either CGRPΑ−/−, CGRPΒ−/−, Ramp1−/−, or Ramp3−/− mice (Dackor et al., 2007).”
InfluentialSelf-citationSerafín, D., Harris, N. R., Nielsen, N. R., Mackie, D. I., & Caron, K. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.009 · Cited by 44
“Further, studies using haploinsufficient RAMP2 mice linked RAMP2 to the endocrine and skeletal systems [46].”
BackgroundMethodInfluentialSelf-citationAdrenomedullin-RAMP2 System in Vascular Endothelial Cells
Koyama, T., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., & Shindo, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29967 · Cited by 42
The expanding repertoire of receptor activity modifying protein (RAMP) function
Klein, K. R., Matson, B. C., & Caron, K. M. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1128875 · Cited by 40
“Only RAMP2 deficiency is embryonic lethal at mid-gestation due to cardiovascular defects and a hypoproliferative lymphatic vasculature, implying that, despite their structural similarity and common association with several GPCRs, RAMPs 1 and 3 are unable to compensate for loss of RAMP2 (Caron & Smithies, 2001; Dackor…”
BackgroundInfluentialSelf-citationWatkins, H. A., Chakravarthy, M., Abhayawardana, R. S., Gingell, J. J., Garelja, M. L., Pardamwar, M., Mcelhinney, J., Lathbridge, A., Constantine, A., Harris, P. W. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688218 · Cited by 42
“Unlike RAMP2 knock-out mice, these animals survive into old age and exhibit normal angiogenesis (12, 16).”
BackgroundVázquez, R., Riveiro, M. E., Berenguer‐Daizé, C., O’Kane, A. A., Gormley, J. A., Touzelet, O., Rezaï, K., Békradda, M., & Ouafik, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.589218 · Cited by 41
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
Walker, C. S., Aitken, J. F., Amarsingh, G. V., Zhang, S., & Cooper, G. J. S. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01125-9 · Cited by 40
“Ramp2 genetic models have not been extensively investigated for different metabolic phenotypes; this is probably because knockouts are embryonically lethal and haplo-insufficient mice have impaired fertility 45 .”
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 40
“Ramp1 ( − / − ) mice have hypertension and display dysregulated immune responses, whereas Ramp3 ( − / − ) mice appear normal until old age, at which point they have decreased weight, indicating defects in metabolism [122,124].”
Grieco, P., & Gomez-Monterrey, I. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.021 · Cited by 37
Kong, H., You, N., Chen, H., Teng, Y., Liu, Y., Lv, Y.-P., Mao, F.-Y., Cheng, P., Chen, W., Zhao, Z., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2391-6 · Cited by 37
Lymphatic Function and Dysfunction in the Context of Sex Differences
Trincot, C. E., & Caron, K. M. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00051 · Cited by 37
Self-citationAdrenomedullin: Not Just Another Gastrointestinal Peptide
Martínez-Herrero, S., & Martínez, A. (2022) · Biomolecules · doi:10.3390/biom12020156 · Cited by 36
“Surprisingly, no survival problems were observed when the expression of RAMP3 was totally suppressed [44].”
BackgroundIdentification of key residues involved in adrenomedullin binding to the AM 1 receptor
Watkins, H. A., Au, M., Bobby, R., Archbold, J. K., Abdul-Manan, N., Moore, J., Middleditch, M., Williams, G., Brimble, M. A., Dingley, A. J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12118 · Cited by 33
“…thin blood vessel walls and significant defects observed in the vascular systems of AM, CLR and RAMP2 knock-out mice can be explained by abnormalities in the blood and lymphatic vasculature (Caron and Smithies, 2001; Dackor et al., 2006; 2007; Fritz-Six et al., 2008; Ichikawa-Shindo et al., 2008).”
BackgroundAdrenomedullin in lymphangiogenesis: from development to disease
Klein, K. R., & Caron, K. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1921-3 · Cited by 31
Self-citationDunworth, W. P., & Caron, K. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185066 · Cited by 29
Self-citationArrigoni, S., Foll, C. L., Cabak, A., Lundh, S. H., Raun, K., John, L. M., & Lutz, T. A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15376 · Cited by 30
“…RAMP1 forward TCATGGGGACCTTTAGGTAAGC, RAMP1 reverse ACAGCAATCCTTCT ACCTCAACAC, RAMP3 WT band is detected using R3–1: GTGCTCAAGGGTTCTG TCTG and R3–10: GACCTGGTTCATCTCTGGCTCC and RAMP3 null band is detected using R3–10: GACCTGG TTCATCTCTGGCTCC and neo-60: GCTTCCTCTTG CAAAACCACA (Dackor et al., 2007).”
BackgroundMethodBarrick, C. J., Lenhart, P., Dackor, R. T., Nagle, E., & Caron, K. M. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.10.021 · Cited by 29
“As previously reported [25], we again found no significant differences in MAP between Ramp3−/− and wild-type mice (data not shown), and thus data was pooled.”
BackgroundMethodResultSelf-citationAdrenomedullin regulates intestinal physiology and pathophysiology
Martínez-Herrero, S., & Martínez, A. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.02.004 · Cited by 30
Nr4a1 Is Required for Fasting-Induced Down-Regulation of Pparγ2 in White Adipose Tissue
Duszka, K., Bogner‐Strauß, J. G., Hackl, H., Rieder, D., Neuhold, C., Prokesch, A., Trajanoski, Z., & Krogsdam, A. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1248 · Cited by 27
“Genes with highly reduced expression in the Nur77 / mice included the transcriptional cosupressor, brain abundant, membrane attached signal protein 1 (Basp1) (63), the WNT signaling regulator, -catenin (Ctnnb1) (80-kDa variant) (64), and the G protein-coupled receptor signal regulator, receptor (calcitonin) activity m…”
BackgroundCagrilintide lowers bodyweight through brain amylin receptors 1 and 3
Carvas, A. O., Leuthardt, A. S., Kulka, P., Lommi, G., Hassan, S., Coester, B., Lundh, S. H., Pers, T. H., Secher, A. L., Raun, K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105836 · Cited by 29
Understanding RAMPs Through Genetically Engineered Mouse Models
Kadmiel, M., Fritz-Six, K. L., & Caron, K. M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-2364-5_5 · Cited by 24
Self-citationRegulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system
Shindo, T., Tanaka, M., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Yamauchi, A., & Sakurai, T. (2018) · Peptides · doi:10.1016/j.peptides.2018.04.004 · Cited by 28
Uddin, J., Yano, H., Parkhurst, C. N., Zhang, W., Ahmed, A., de Godoy, V. R., Wei, Q., Panchakshari, R. A., Henninot, A., Dasgupta, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02243-2 · Cited by 23
Uetake, R., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Iesato, Y., Yoshizawa, T., Koyama, T., Yang, L., Toriyama, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087667 · Cited by 24
“Interestingly, RAMP22/2 phenotypes are embryonically lethal and similar to AM2/2 phenotypes [25,30,48,49,50].”
BackgroundCardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice
Pawlak, J. B., Wetzel‐Strong, S. E., Dunn, M. K., & Caron, K. M. (2016) · Peptides · doi:10.1016/j.peptides.2016.12.002 · Cited by 24
Self-citationEffects of sugar solutions on hypothalamic appetite regulation
Colley, D. L., & Castonguay, T. W. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.11.025 · Cited by 22
“Another function of RAMP3 is to complex with calcitonin receptor-like receptor (CLR) to form adrenomedullin receptors [30,31].”
Menon, R., Shrestha, A. K., & Shivanna, B. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.112 · Cited by 20
“Calcrl−/− and RAMP2−/− mice have a phenotype identical to that of AM−/− mice [13, 15, 17], whereas RAMP3−/− mice survive with few phenotypic defects [18].”
Shindo, T., Sakurai, T., Kamiyoshi, A., Ichikawa-Shindo, Y., Shimoyama, N., Iinuma, N., Arai, T., & Miyagawa, S. (2013) · Current Protein & Peptide Science · doi:10.2174/13892037113149990052 · Cited by 19
“In fact, RAMP3-/- mice live apparently normally with no abnormalities in vascular development([49]).”
BackgroundSkovbjerg, G., Roostalu, U., Hansen, H. H., Lutz, T. A., Foll, C. L., Salinas, C. G., Skytte, J. L., Jelsing, J., Vrang, N., & Hecksher‐Sørensen, J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15254 · Cited by 19
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor
Avgoustou, P., Jailani, A. B. A., Zirimwabagabo, J., Tozer, M. J., Gibson, K. R., Glossop, P. A., Mills, J. E. J., Porter, R. A., Blaney, P. M., Bungay, P. J., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00032 · Cited by 21
RAMPs regulate signalling bias and internalisation of the GIPRPreprint
Harris, M., Mackie, D. I., Pawlak, J. B., Carvalho, S., Truong, T. T., Safitri, D., Yeung, H. Y., Routledge, S. J., Harper, M. T., Al‐Zaid, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.08.436756 · Cited by 23
“After its release, it is rapidly broken down by dipeptidylpeptidase IV (DPPIV) 16 to GIP (3-42), a weak partial agonist.”
BackgroundMethodSelf-citationBendriss, G., Dussault, N., Fernandez-Sauze, S., Berenguer‐Daizé, C., Sigaud, R., Delfino, C., Cayol, M., Métellus, P., Chinot, O. L., Mabrouk, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3167 · Cited by 18
“The genetic ablation of Adm [4, 5], calcrl [6], Ramp2 [7–9] or the enzyme responsible for functional AM amidation, peptidylglycine alpha-amidating monooxygenase ( PAM ) [10] all result in midgestational lethality associated with severe interstitial edema and cardiovascular defects.”
Pathophysiological roles of adrenomedullin-RAMP2 system in acute and chronic cerebral ischemia
Igarashi, K., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Yamauchi, A., Toriyama, Y., Tanaka, M., Liu, T., Xian, X., et al. (2014) · Peptides · doi:10.1016/j.peptides.2014.08.013 · Cited by 18
“In contrast, RAMP1−/− and RAMP3−/− mice are born normally [1,35].”
Jailani, A. B. A., Bigos, K. J. A., Avgoustou, P., Egan, J. L., Hathway, R. A., Skerry, T. M., & Richards, G. O. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2090541 · Cited by 17
“defects including lymphatic vascular development [55], tissue-specific RAMP2 knockout [56] or heterozygous mouse models [57] have been used to interrogate the role of RAMP2 in cancer.”
BackgroundRoles of CLR/RAMP Receptor Signaling in Reproduction and Development
Chang, C. L., & Hsu, S. Y. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990056 · Cited by 21
Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation
Fischer, J., Schönauer, R. A.-R., Els‐Heindl, S., Bierer, D. E., Koebberling, J., Riedl, B., & Beck‐Sickinger, A. G. (2019) · Journal of Peptide Science · doi:10.1002/psc.3147 · Cited by 17
Receptor Activity Modifying Proteins and Their Potential as Drug Targets
Wootten, D. L., Simms, J., Hay, D. L., Christopoulos, A., & Sexton, P. M. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)91003-x · Cited by 16
“The RAMP2 and RAMP3 knockout mice each displayed distinct phenotypes, revealing divergent roles for these two proteins despite their association with CLR to yield pharmacologically similar AM receptors.(45) Deletion of the RAMP2 gene resulted in a lethal phenotype, of which the likely causes were abnormalities in the…”
BackgroundAdrenomedullin as a Growth and Cell Fate Regulatory Factor for Adult Neural Stem Cells
Martínez-Herrero, S., Larráyoz, I. M., Ochoa‐Callejero, L., Garcı́a-Sanmartı́n, J., & Martı́nez, A. (2012) · Stem Cells International · doi:10.1155/2012/804717 · Cited by 15
“RAMP3-null mice appear normal until old age (9-10 months), at which point they have less weight than their wild-type littermates [54].”
BackgroundKechele, D. O., Dunworth, W. P., Trincot, C. E., Wetzel‐Strong, S. E., Li, M., Ma, H., Liu, J., & Caron, K. M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07191 · Cited by 15
“Mouse Studies Previously published SvEv-Ramp2 and Calcrl mice were both fully backcrossed (>10 generations) onto a C57BL/6J genetic background for these studies.(5,9) A novel endothelial-specific Ramp2 transgenic mouse was generated and crossed to the Ramp2 mice.”
BackgroundSelf-citationDistal control of the pig whey acidic protein (WAP) locus in transgenic mice
Saïdi, S., Rival‐Gervier, S., Daniel-Carlier, N., Thépot, D., Morgenthaler, C., Viglietta, C., Prince, S., Passet, B., Houdebine, L., & Jolivet, G. (2007) · Gene · doi:10.1016/j.gene.2007.06.023 · Cited by 15
Adrenomedullin: A potential therapeutic target for retinochoroidal disease
Iesato, Y., Yuda, K., Chong, K. T. Y., Tan, X., Murata, T., Shindo, T., & Yanagi, Y. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.01.001 · Cited by 19
Genome-Wide Association Study of Weaning Traits in Lori-Bakhtiari Sheep
Almasi, M., Zamani, P., Mirhoseini, S. Z., & Moradi, M. H. (2020) · Annals of Animal Science · doi:10.2478/aoas-2020-0014 · Cited by 13
Neural Stem Cells in the Adult Brain: From Benchside to Clinic
González-Pérez, Ó., García‐Verdugo, J. M., Quiñones‐Hinojosa, A., Luquín, S., Gudiño‐Cabrera, G., & González-Castañeda, R. E. (2012) · Stem Cells International · doi:10.1155/2012/378356 · Cited by 13
“These studies strongly suggest that HGF-containing gelatin hydrogel is likely to be useful to enhance neuronal regeneration after stroke.”
BackgroundInfluentialBabin, K. M., Karim, J. A., Gordon, P. H., Lennon, J., Dickson, A., & Pioszak, A. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104785 · Cited by 12
Kadmiel, M., Matson, B. C., Espenschied, S. T., Lenhart, P., & Caron, K. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181597 · Cited by 15
Self-citationFunctional characterization of two human receptor activity-modifying protein 3 variants
Bailey, R. J., Bradley, J., Poyner, D. R., Rathbone, D. L., & Hay, D. L. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.016 · Cited by 12
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_6 · Cited by 15
Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors
Piper, N. B. C., Whitfield, E. A., Stewart, G. D., Xu, X., & Furness, S. G. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115115 · Cited by 11
Leuthardt, A. S., Boyle, C. N., Raun, K., Lutz, T. A., John, L. M., & Foll, C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175912 · Cited by 12
Prakash, J., Herlin, M., Kumar, J., Garg, G., Åkesson, K., Grabowski, P., Skerry, T. M., Richards, G. O., & McGuigan, F. E. (2019) · Gene · doi:10.1016/j.gene.2019.100009 · Cited by 10
“Although the mechanisms underlying the results of this present study are unclear, in an animal study (Dackor et al., 2007) Dackor et al.”
BackgroundResultReceptor activity–modifying protein 3 enhances GLP-1-mediated insulin secretion
Pearce, A., Kumari, P., Sisk, C. M., Harris, M., Yeung, H. Y., Winfield, S., Caron, K. M., & Ladds, G. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110604 · Cited by 10
“RAMPs are expressed in many of the tissues of the endocrine system, such as the thyroid and hypothalamus, and global RAMP KO in rodents causes dysregulation of body weight and glycemic control (14, 15).”
Self-citationRole of Adrenomedullin in the Growth and Differentiation of Stem and Progenitor Cells
Larráyoz, I. M., Ochoa‐Callejero, L., García-Sanmartín, J., Vicario‐Abejón, C., & Martínez, A. (2012) · International review of cytology · doi:10.1016/b978-0-12-394308-8.00005-4 · Cited by 10
“Thus, studies of RAMP KO mice have shown that RAMP2 and RAMP3 have distinct physiological functions throughout embryogenesis, adulthood, and old age, despite mediating similar AM and AM2 signaling complexes with CLR (Dackor et al., 2007).”
BackgroundCalcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Receptor activity-modifying proteins of adrenomedullin (RAMP2/3): Roles in the pathogenesis of ARDS.
Kasahara, T., Tanaka, M., Zhao, Y., Kamiyoshi, A., Sakurai, T., Ichikawa‐Shindo, Y., Kawate, H., Matsuda, Y., Zhang, Y., Guo, Q., et al. (2023) · Peptides · doi:10.1016/j.peptides.2023.171118 · Cited by 6
Systems Pharmacology: Enabling Multidimensional Therapeutics
Maudsley, S. R., Leysen, H., van Gastel, J., & Martin, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00017-7 · Cited by 6
Activation of Calcitonin Receptor and Calcitonin Receptor-like Receptor by Membrane-anchored Ligands
Chang, C. L., Park, J., & Hsu, S. Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020040 · Cited by 5
Parameswaran, N., & Spielman, W. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_1 · Cited by 5
Lu, C., Huang, S., Cheng, S., Lin, C., Hsu, Y., Yao, C., Dong, F., Hung, C., & Kuo, H. (2023) · Molecular Ecology · doi:10.1111/mec.16875 · Cited by 5
“Deficiencies in RAMP3 and PSME3 had been shown to cause reduced body weight and retarded postnatal growth in mice, respectively (Dackor et al., 2007; Murata et al., 1999).”
BackgroundThe Calcitonin Peptide Family: What Can We Learn from Receptor Knock Out and Transgenic Mice
Born, W., & Fischer, J. A. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_5 · Cited by 4
Adrenomedullin Promotes Rat Trophoblast Stem Cell Differentiation1
Gao, H., Liebenthal, D. A., Yallampalli, U., & Yallampalli, C. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.120378 · Cited by 3
“In addition, several studies demonstrated that RAMP2 is required for normal pregnancy and fetal development, and genetic deletion of Ramp2 is embryonically lethal [30, 31], while genetic deletion of Ramp1 or Ramp3 does not cause a grossly abnormal phenotype [30, 32].”
BackgroundNishikimi, T., Kuwahara, K., Nakagawa, Y., Kangawa, K., & Nakao, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00002-6 · Cited by 9
Lessons Learned from CGRP Mutant Mice
Sowers, L. P., Tye, A. E., & Russo, A. F. (2017) · Wiley eBooks · doi:10.1002/9781118967225.ch10 · Cited by 4
Caracterización de un modelo de colitis en ratones knockout inducibles para adrenomedulina
Martínez-Herrero, S. (2014) · Cited by 1
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Pacharne, S., Livesey, M. R., Kadmiel, M., Wang, N., Caron, K. M., Richards, G. O., & Skerry, T. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.807882 · Cited by 1
“In 2007, there were first reports of the Ramp1 (36) and Ramp2, Ramp2 and the Ramp3 mouse models (37) which improved understanding of physiological relevance of the Ramp genes.”
BackgroundMethodResultInfluentialSelf-citationCalcitonin receptors in GtoPdb v.2023.1
Garelja, M. L., Hay, D. L., Poyner, D. R., & Walker, C. S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2023.1 · Cited by 3
The role of receptor activity-modifying proteins in obesity and diabetes mellitus
Malcharek, M. A., Pearce, A., Brighton, C. A., Hornigold, D. C., & Ladds, G. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0056 · Cited by 2
Broselid, S. (2014) · Lund University Publications (Lund University)
Gene Targeted Mouse Models of Adrenomedullin Signaling
Kadmiel, M., & Caron, K. M. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_6
“Older RAMP3 null mice exhibited decreased body weight compared to agematched wildtype control mice, but longevity was not significantly affected (Dackor et al. 2007).”
BackgroundSelf-citation
Metadata
- Authors
- Dackor, R., Fritz-Six, K., Smithies, O., & Caron, K.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Caron, Kathleen
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 25
- Pages
- 18094-18099
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070351068
- Cited by
- 114
- References
- 26
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 10 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 6 · 2014: 9 · 2013: 4 · 2012: 10
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4953 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Burroughs Wellcome Fund
- GlaxoSmithKline
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL49277, R01HL049277)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 046970, R01HD046970)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- receptor activity-modifying proteins, RAMP2, RAMP3, calcitonin receptor-like receptor, G protein-coupled receptor signaling, knockout mice, subfertility, aging, weight loss, adrenomedullin, calcitonin gene-related peptide, vasodilation, blood pressure, embryonic development, receptor trafficking
- MeSH terms
- Aging, Animals, Blood Pressure, Heart Rate, Heterozygote, Ligands, Membrane Proteins, Protein Binding, Calcitonin Gene-Related Peptide, Gene Deletion, Receptors, Calcitonin, Gene Expression Regulation, Developmental, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 2, Receptor Activity-Modifying Protein 3, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.